Swiss Personal Products Stock News

Valiant Holding AG reported first-quarter 2026 results with net interest income of CHF 100.64 million and net income of CHF 33.24 million, both slightly higher than a year earlier. Despite this modest improvement, investors focused on the bank’s challenging revenue trends. We’ll now examine how these weaker-than-expected earnings in the context of the bank's valuation estimates.

If you are asking whether UBS Group is priced attractively right now, the starting point is to look closely at what the current share price might already be assuming. The stock last closed at CHF 35.03, with returns of 1.5% over 7 days, 8.1% over 30 days, a 8.2% decline year to date, and gains of 38.4% over 1 year, 120.8% over 3 years and 189.1% over 5 years. Recent headlines have focused on UBS Group's role as a major global banking and wealth management group, including its ongoing...

If you are wondering whether Temenos is priced fairly or if the current share price leaves room for upside, it helps to start by looking closely at what the market has been paying for this stock recently. Temenos shares recently closed at CHF 74.20, with returns of 0.4% over 7 days, 2.3% over 30 days, a 9.0% decline year to date, and 22.6% over the past year. Together, these figures present a mixed picture of changing expectations and risk perception. Recent coverage of Temenos has focused...

The investors in ams-OSRAM AG 's ( VTX:AMS ) will be rubbing their hands together with glee today, after the share...

Investors in Logitech International S.A. ( VTX:LOGN ) had a good week, as its shares rose 6.6% to close at CHF81.82...

As you might know, Geberit AG ( VTX:GEBN ) recently reported its quarterly numbers. Geberit reported in line with...

Earnings miss, weaker profit, and new buyback sharpen focus on Alcon stock Alcon (SWX:ALC) reported first quarter 2026 revenue growth supported by recent product launches and market share gains. Profit came under pressure, guidance was reaffirmed, and a US$1.5b share repurchase plan was introduced. See our latest analysis for Alcon. Alcon's latest earnings and the new US$1.5b buyback have coincided with a sharp reset in sentiment, with a 7 day share price return of a 13.6% decline and a 1...

Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...

Sunrise Communications AG ( VTX:SUNN ) stock is about to trade ex-dividend in three days. The ex-dividend date is...

Alcon (SWX:ALC) opened 2026 with Q1 revenue of US$2.7b and basic EPS of US$0.39, setting a clear marker for how the year is starting after a period where trailing 12 month revenue sat at US$10.6b and EPS at US$1.67. Over recent quarters, the company has seen revenue move from US$2.5b in Q4 2024 to around US$2.7b in Q1 2026, while quarterly EPS has ranged from US$0.36 to US$0.71. This gives investors a wide set of earnings outcomes to weigh against a reported trailing net margin of 7.7% and...

Investors may be wondering if Novartis at CHF113.54 is still offering value, or if most of the easy gains are already on the table. The stock is up 25.9% over the last year and 41.9% over 3 years, even though it shows a 1% decline over 7 days, a 7.8% decline over 30 days, and a 4.6% return year to date. Recent headlines have focused on Novartis as a large global pharmaceutical business, with investors watching how its product portfolio and pipeline shape long term expectations. This context...

Temenos (SWX:TEMN) has secured new SaaS core banking agreements with First Abu Dhabi Bank in Saudi Arabia and Questrade in Canada. The company is expanding its SaaS offering on Amazon Web Services to cover end to end digital banking and payments. These updates relate to Temenos' cloud banking platform and its global client reach across the Middle East and North America. For Temenos, a provider of core banking and digital banking software, these wins highlight how large banks and non bank...

Bachem Holding (SWX:BANB) is back in focus after announcing the departure of Chief Commercial Officer Torsten Wöhr. CEO Anne-Kathrin Stoller is set to temporarily assume commercial responsibilities from May 25, 2026. See our latest analysis for Bachem Holding. The leadership change comes as Bachem Holding’s share price trades at CHF75.45, with a 7 day share price return of 10.71% and a year to date share price return of 29.08%. The 1 year total shareholder return of 54.39% contrasts with a 3...

In late April 2026, Sandoz Group reported Q1 results showing 3% net sales growth at constant currency, led by 18% growth in biosimilars, while also confirming its full-year 2026 outlook for mid- to high-single-digit sales growth and core EBITDA margin expansion. The company also announced a new partnership with Samsung Bioepis covering up to five biosimilar assets, a move that materially broadens its pipeline and reinforces its push into higher-value biologic medicines. We’ll now examine how...

Huber+Suhner (SWX:HUBN) is back on investor radars after expanding its work with Microsoft on hollow core fiber, supplying cables and connectors that are already deployed within the Azure cloud network. See our latest analysis for Huber+Suhner. That Microsoft HCF agreement arrives as momentum in the shares has already been strong, with a 30 day share price return of 22.7% and a year to date gain of 48.04% alongside a 1 year total shareholder return above 200%, suggesting sentiment has shifted...

Zurich Insurance Group (SWX:ZURN) is expanding its technology footprint with a new Global Capability Centre in Hyderabad, India. The centre is aimed at supporting its AI driven transformation and broader digital ambitions across the group. See our latest analysis for Zurich Insurance Group. Despite the new capability centre and recent digital leadership changes in Asia Pacific, Zurich Insurance Group’s share price shows a 1 month share price return decline of 4.73% and a year to date share...

Dividend approval and board refresh put Galderma in focus Galderma Group (SWX:GALD) drew fresh attention after its Annual General Meeting approved a CHF 0.35 per share dividend from capital contribution reserves and confirmed new Board members, including an independent director and two L’Oréal representatives. See our latest analysis for Galderma Group. At a CHF163.8 share price, Galderma’s recent AGM outcomes appear to have supported sentiment, with 1-month and 3-month share price returns of...

Q1 trading update puts SGS (SWX:SGSN) in focus SGS (SWX:SGSN) has come onto investors’ radar after its Q1 2026 sales and trading statement call on 23 April, prompting fresh attention on how the testing, inspection and certification group is currently positioned. See our latest analysis for SGS. Following the Q1 2026 trading update, SGS’s share price at CHF84.64 reflects mixed momentum, with a 1 day share price return of 0.76% but a 90 day share price return showing an 8.79% decline, while the...

In late April 2026, SIG announced a two-phase expansion of its Querétaro plant that will double capacity to 3 billion packs annually by 2028, integrate processes like extrusion, and support nearshoring by shifting some production from Europe to Mexico. This move positions Querétaro as SIG’s main North American manufacturing hub, improving regional responsiveness for food and beverage customers while modestly increasing local employment and operational scale in Mexico. We’ll now consider how...

Wondering if Logitech International at around US$76.74 is priced for opportunity or already reflects the story? This article walks you through what the numbers are actually saying about the stock today. The share price shows mixed recent returns, with 2.0% over the past week and 6.1% over the last month, set against a 3.4% decline year to date but a 25.5% gain over one year and 42.9% over three years, while the five year return stands at a 17.3% decline. Recent headlines around Logitech have...

If you are wondering whether Roche Holding is priced attractively or trading rich right now, the starting point is to look past the ticker and focus on what the current share price implies about value. Roche Holding shares recently closed at CHF318.40, with returns of 2.0% decline over 7 days, 1.2% over 30 days, 2.2% decline year to date, 21.9% over 1 year, 25.2% over 3 years, and 25.5% over 5 years. This gives you a mix of short term softness and longer term gains to interpret. Recent news...

As the pan-European STOXX Europe 600 Index experiences a decline, with defensive sectors like utilities and telecoms showing relative strength amid geopolitical tensions, investors are increasingly on the lookout for overlooked opportunities in the market. In this environment, identifying stocks with strong fundamentals and resilience to economic fluctuations can be crucial for navigating uncertainty.

Why the latest trial results matter for Roche Holding (SWX:ROG) Roche Holding (SWX:ROG) has put fresh clinical data in front of investors, with fenebrutinib hitting primary and secondary endpoints in two Phase III trials in relapsing multiple sclerosis. This comes alongside FDA acceptance of a supplemental filing for Gazyva/Gazyvaro in systemic lupus erythematosus. The FENhance 1 and 2 studies reported that fenebrutinib cut annualised relapse rates by 51.1% and 58.5% versus teriflunomide over...

UBS Group Q1 2026 Earnings Snapshot UBS Group (SWX:UBSG) has opened Q1 2026 reporting season following a solid 2025 finish, with Q4 revenue at US$12.8 billion and basic EPS of US$0.39 anchoring the latest set of numbers. The bank reported quarterly revenue rising from US$11.4 billion in Q4 2024 to US$12.8 billion in Q4 2025, while trailing twelve month EPS reached US$2.46 alongside net income of US$7.8 billion. This provides a clear view of how earnings have moved in line with the top line...